Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Remission and regression of diabetic nephropathy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Dietary sodium: where science and policy conflict: impact of the 2013 IOM Report on Sodium Intake in Populations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hypertension and liver disease.

    Publikation: Bidrag til tidsskriftReview

Vis graf over relationer

Diabetic kidney disease is considered to be an irreversible and inexorable progressive disease. Therefore, prevention of development of ESRD is extremely important. Animal studies have demonstrated that regression of existing renal morphologic lesions is feasible. In a sizable fraction of type 1 diabetic patients with overt nephropathy, remission (decrease in albuminuria to <300 mg/24 h) was obtained (31%), and regression of diabetic nephropathy (rate of decline in GFR < or = 1 mL/min/y), achieved (22%) by aggressive antihypertensive treatment. Furthermore, remission of nephrotic-range albuminuria (from >2500 mg/24 h to <600 mg/24 h) have been demonstrated to be achievable in one fifth of patients with nephrotic-range albuminuria. Remission of nephrotic-range albuminuria was associated with a reduction in decline in GFR and improved survival free of ESRD. However, to prevent development of ESRD in diabetic patients, an aggressive multifactorial approach, aiming at lowering blood pressure and albuminuria, and improving glycemic control, must be applied.

OriginalsprogEngelsk
TidsskriftCurrent Hypertension Reports
Vol/bind6
Udgave nummer5
Sider (fra-til)377-82
Antal sider6
ISSN1522-6417
StatusUdgivet - 2004
Eksternt udgivetJa

ID: 50154001